Literature DB >> 25687910

Biomarkers: exceptional responders-discovering predictive biomarkers.

Naoko Takebe1, Lisa McShane1, Barbara Conley1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25687910     DOI: 10.1038/nrclinonc.2015.19

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

Review 1.  National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.

Authors:  Jeffrey Abrams; Barbara Conley; Margaret Mooney; James Zwiebel; Alice Chen; John J Welch; Naoko Takebe; Shakun Malik; Lisa McShane; Edward Korn; Mickey Williams; Louis Staudt; James Doroshow
Journal:  Am Soc Clin Oncol Educ Book       Date:  2014

2.  Molecular analysis for therapy choice: NCI MATCH.

Authors:  Barbara A Conley; James H Doroshow
Journal:  Semin Oncol       Date:  2014-05-22       Impact factor: 4.929

3.  Learning from exceptional drug responders.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2014-06       Impact factor: 84.694

4.  Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.

Authors:  Hikmat Al-Ahmadie; Gopa Iyer; Marcel Hohl; Saurabh Asthana; Akiko Inagaki; Nikolaus Schultz; Aphrothiti J Hanrahan; Sasinya N Scott; A Rose Brannon; Gregory C McDermott; Mono Pirun; Irina Ostrovnaya; Philip Kim; Nicholas D Socci; Agnes Viale; Gary K Schwartz; Victor Reuter; Bernard H Bochner; Jonathan E Rosenberg; Dean F Bajorin; Michael F Berger; John H J Petrini; David B Solit; Barry S Taylor
Journal:  Cancer Discov       Date:  2014-06-16       Impact factor: 39.397

5.  Genome sequencing identifies a basis for everolimus sensitivity.

Authors:  Gopa Iyer; Aphrothiti J Hanrahan; Matthew I Milowsky; Hikmat Al-Ahmadie; Sasinya N Scott; Manickam Janakiraman; Mono Pirun; Chris Sander; Nicholas D Socci; Irina Ostrovnaya; Agnes Viale; Adriana Heguy; Luke Peng; Timothy A Chan; Bernard Bochner; Dean F Bajorin; Michael F Berger; Barry S Taylor; David B Solit
Journal:  Science       Date:  2012-08-23       Impact factor: 47.728

6.  Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

Authors:  Nikhil Wagle; Brian C Grabiner; Eliezer M Van Allen; Eran Hodis; Susanna Jacobus; Jeffrey G Supko; Michelle Stewart; Toni K Choueiri; Leena Gandhi; James M Cleary; Aymen A Elfiky; Mary Ellen Taplin; Edward C Stack; Sabina Signoretti; Massimo Loda; Geoffrey I Shapiro; David M Sabatini; Eric S Lander; Stacey B Gabriel; Philip W Kantoff; Levi A Garraway; Jonathan E Rosenberg
Journal:  Cancer Discov       Date:  2014-03-13       Impact factor: 39.397

7.  Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.

Authors:  Christine M Lovly; Nerina T McDonald; Heidi Chen; Sandra Ortiz-Cuaran; Lukas C Heukamp; Yingjun Yan; Alexandra Florin; Luka Ozretić; Diana Lim; Lu Wang; Zhao Chen; Xi Chen; Pengcheng Lu; Paul K Paik; Ronglai Shen; Hailing Jin; Reinhard Buettner; Sascha Ansén; Sven Perner; Michael Brockmann; Marc Bos; Jürgen Wolf; Masyar Gardizi; Gavin M Wright; Benjamin Solomon; Prudence A Russell; Toni-Maree Rogers; Yoshiyuki Suehara; Monica Red-Brewer; Rudy Tieu; Elisa de Stanchina; Qingguo Wang; Zhongming Zhao; David H Johnson; Leora Horn; Kwok-Kin Wong; Roman K Thomas; Marc Ladanyi; William Pao
Journal:  Nat Med       Date:  2014-08-31       Impact factor: 53.440

  7 in total
  17 in total

Review 1.  Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.

Authors:  Ignacio Garrido-Laguna; Manuel Hidalgo
Journal:  Nat Rev Clin Oncol       Date:  2015-03-31       Impact factor: 66.675

Review 2.  Refining the treatment of NSCLC according to histological and molecular subtypes.

Authors:  Anish Thomas; Stephen V Liu; Deepa S Subramaniam; Giuseppe Giaccone
Journal:  Nat Rev Clin Oncol       Date:  2015-05-12       Impact factor: 66.675

3.  Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach.

Authors:  Junfei Zhao; Feixiong Cheng; Yuanyuan Wang; Carlos L Arteaga; Zhongming Zhao
Journal:  Mol Cell Proteomics       Date:  2015-12-09       Impact factor: 5.911

Review 4.  Translating cancer genomes and transcriptomes for precision oncology.

Authors:  Sameek Roychowdhury; Arul M Chinnaiyan
Journal:  CA Cancer J Clin       Date:  2015-11-03       Impact factor: 508.702

Review 5.  Transforming Biomarker Development with Exceptional Responders.

Authors:  Philip Jonsson; Barry S Taylor
Journal:  Trends Cancer       Date:  2017-12-06

Review 6.  Going to extremes: determinants of extraordinary response and survival in patients with cancer.

Authors:  Flurina A M Saner; Alan Herschtal; Brad H Nelson; Anna deFazio; Ellen L Goode; Susan J Ramus; Ahwan Pandey; Jessica A Beach; Sian Fereday; Andrew Berchuck; Stephanie Lheureux; Celeste Leigh Pearce; Paul D Pharoah; Malcolm C Pike; Dale W Garsed; David D L Bowtell
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

7.  Precision oncology in the age of integrative genomics.

Authors:  Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908

Review 8.  Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?

Authors:  Veronique G LeBlanc; Marco A Marra
Journal:  Cancers (Basel)       Date:  2015-09-23       Impact factor: 6.639

9.  The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.

Authors:  Barbara A Conley; Lou Staudt; Naoko Takebe; David A Wheeler; Linghua Wang; Maria F Cardenas; Viktoriya Korchina; Jean Claude Zenklusen; Lisa M McShane; James V Tricoli; Paul M Williams; Irina Lubensky; Geraldine O'Sullivan-Coyne; Elise Kohn; Richard F Little; Jeffrey White; Shakun Malik; Lyndsay N Harris; Bhupinder Mann; Carol Weil; Roy Tarnuzzer; Chris Karlovich; Brian Rodgers; Lalitha Shankar; Paula M Jacobs; Tracy Nolan; Sean M Berryman; Julie Gastier-Foster; Jay Bowen; Kristen Leraas; Hui Shen; Peter W Laird; Manel Esteller; Vincent Miller; Adrienne Johnson; Elijah F Edmondson; Thomas J Giordano; Benjamin Kim; S Percy Ivy
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 11.816

Review 10.  Confronting the Care Delivery Challenges Arising from Precision Medicine.

Authors:  Elise C Kohn; S Percy Ivy
Journal:  Front Oncol       Date:  2016-04-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.